CytoSorbents to Report First Quarter 2024 Operating and Financial Results

6d ago, source:

Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac ...

Cytosorbents Corp

11d ago, source: U.S. News & World Report

For most investors, the best investment strategy is to buy good stocks and hold them for the long run.

CytoSorbents Reports Fourth Quarter and Full Year 2023 Results

1mon ago, source: Morningstar

CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification via its proprietary ...

CytoSorbents to present STAR-T trial results at AATS

16d ago, source: Investing

PRINCETON – CytoSorbents Corporation (NASDAQ:CTSO), known for its blood purification technologies, has announced that its STAR-T trial results will be presented at the upcoming 104th Annual ...

Cytosorbents Corporation (CTSO)

4d ago, source: Yahoo Finance

*Close price adjusted for splits.**Close price adjusted for splits and dividend and/or capital gain distributions. Loading more data ...

CytoSorbents Reports First Quarter 2023 Results

1mon ago, source: ADVFN

PRINCETON, N.J., May 02, 2023 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery ...

Cytosorbents Corp.

18d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

CytoSorbents Reports Fourth Quarter and Full Year 2023 Results

1mon ago, source: Yahoo Finance

PRINCETON, N.J., March 14, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery ...